Cover Image
Market Research Report

Alopecia Market Size, Share & Trends Analysis Report By Disease Type, By End Use (Homecare Settings, Dermatology Clinics), By Sales Channel (OTC, Prescription), By Gender, And Segment Forecasts, 2019 - 2026

Published by Grand View Research, Inc. Product code 361257
Published Content info 118 Pages
Delivery time: 2-3 business days
Price
Back to Top
Alopecia Market Size, Share & Trends Analysis Report By Disease Type, By End Use (Homecare Settings, Dermatology Clinics), By Sales Channel (OTC, Prescription), By Gender, And Segment Forecasts, 2019 - 2026
Published: July 4, 2019 Content info: 118 Pages
Description

The global alopecia market size is anticipated to reach USD 4.8 billion by 2026, according to a report published by Grand View Research, Inc., registering an 8.3% CAGR during the forecast period. The market is expected to be driven by increase in disease prevalence, technological advancements, and rise in per-capita healthcare expenditures across the globe.

The disease prevalence is increasing due to changing lifestyle patterns, such as increased consumption of alcohol and tobacco, changing food habits, high level of stress, and rising geriatric population. These factors are expected to boost the market over the forecast period. In addition, rising incidences of chronic diseases such as Polycystic Ovary Syndrome (PCOS), cancer, and rheumatoid arthritis are likely to fuel market growth.

Statistics presented by the National Alopecia Areata Foundation states that 147 million people worldwide, including 6.8 million people in U.S. alone, are affected by alopecia areata. Growing patient awareness about the disease and its treatment is anticipated to contribute to alopecia market growth. For instance, the Treatment Development Program (TDP) by National Alopecia Areata Foundation has resulted in an increase in research studies pertaining to this condition.

Currently, there are two FDA-approved therapeutics for the condition-Rogaine and Propecia. Generic penetration has significantly increased, following patent expirations of both drugs. However, impending launch of several promising pipeline candidates, such as Jakafi (ruxolitinib), Xeljanz (tofacitinib), Breezula (clascoterone), Lumigan (Bimatoprost), and SM04554 is expected to significantly drive the market in the near future.

Reimbursement coverage for treatment of this medical condition is one of the major challenges in this therapeutic landscape. Since most treatment modalities for this condition are considered cosmetic procedures and not medically essential, they are generally not covered under insurance. Out-of-pocket costs for this disease treatment usually include frequent doctor visits, prescription drug copays, and coinsurance for procedures.

Further key findings from the study suggest:

  • High disease prevalence due to changing lifestyle patterns is the main factor driving the alopecia market
  • Globally, lack of reimbursement policies will continue to restrain growth
  • By disease type, alopecia areata accounted for more than 30.0% of the revenue in 2018
  • Androgenetic alopecia, on the other hand, is expected to exhibit a CAGR of over 10.0% through 2026
  • Homecare end-use settings are likely to be driven by increasing availability of OTC products and patient convenience
  • Geographically, Asia Pacific is expected to demonstrate the fastest regional growth
Table of Contents
Product Code: 978-1-68038-856-5

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Alopecia Market Variables, Trends & Scope

  • 3.1. Alopecia Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing global prevalence of alopecia
      • 3.4.1.2. Rise in global healthcare expenditure
      • 3.4.1.3. Growing incidence of chronic diseases
      • 3.4.1.4. Technological advancements in alopecia treatment
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Lack of reimbursement policies
  • 3.5. Alopecia Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power: (Low due to large availability of products)
      • 3.5.1.2. Buyer power: (High due to variety of options)
      • 3.5.1.3. Substitution threat: (High due to replacements by transplantation)
      • 3.5.1.4. Threat from new entrant: (High due to generic penetration)
      • 3.5.1.5. Competitive rivalry: (High due to mergers & acquisitions by major players)
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Environmental landscape
      • 3.5.2.3. Social landscape
      • 3.5.2.4. Technology landscape
      • 3.5.2.5. Legal landscape
    • 3.5.3. Major deals & strategic alliances analysis
      • 3.5.3.1. Joint ventures
      • 3.5.3.2. Mergers & acquisitions
      • 3.5.3.3. Licensing & partnership
      • 3.5.3.4. Technology collaborations
      • 3.5.3.5. Strategic divestments

Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis

  • 4.1. Definitions & Scope
  • 4.2. Disease Type Market Share Analysis, 2018 & 2026
  • 4.3. Alopecia Market, by Disease Type Type, 2014 to 2026
  • 4.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 4.4.1. Alopecia areata
      • 4.4.1.1 Alopecia areta market, 2014 - 2026 (USD Million)
    • 4.4.2. Cicatricial alopecia
      • 4.4.2.1 Cicatricial alopecia market, 2014 - 2026 (USD Million)
    • 4.4.3. Traction alopecia
      • 4.4.3.1 Traction alopecia market, 2014 - 2026 (USD Million)
    • 4.4.4. Alopecia totalis
      • 4.4.4.1 Alopecia totalis market, 2014 - 2026 (USD Million)
    • 4.4.5. Alopecia universalis
      • 4.4.5.1 Alopecia universalis market, 2014 - 2026 (USD Million)
    • 4.4.6. Androgenetic alopecia
      • 4.4.6.1 Androgenetic alopecia market, 2014 - 2026 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1 Others alopecia market, 2014 - 2026 (USD Million)

Chapter 5. Alopecia Market: End Use Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. End Use Market Share Analysis, 2018 & 2026
  • 5.3. Alopecia Market, by End Use, 2014 to 2026
  • 5.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 5.4.1. Dermatology clinics
      • 5.4.1.1 Dermatology clinics, 2014 - 2026 (USD Million)
    • 5.4.2. Homecare setting
      • 5.4.2.1 Homecare setting market, 2014 - 2026 (USD Million)

Chapter 6. Alopecia Market: Sales Channel Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Sales channel Market Share Analysis, 2018 & 2026
  • 6.3. Alopecia Market, by Sales Channel, 2014 to 2026
  • 6.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 6.4.1. Prescriptions
      • 6.4.1.1 Prescriptions, 2014 - 2026 (USD Million)
    • 6.4.2. Homecare setting
      • 6.4.2.1 Homecare setting market, 2014 - 2026 (USD Million)

Chapter 7. Alopecia Market: Gender Estimates & Trend Analysis

  • 7.1. Definitions & Scope
  • 7.2. Gender Market Share Analysis, 2018 & 2026
  • 7.3. Alopecia Market, by Gender, 2014 to 2026
  • 7.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 7.4.1. Male
      • 7.4.1.1 Male alopecia market, 2014 - 2026 (USD Million)
    • 7.4.2. Female
      • 7.4.2.1 Female alopecia market, 2014 - 2026 (USD Million)

Chapter 8 Alopecia Market: Regional Estimates & Trend Analysis

  • 8.1 Alopecia Market: Regional Movement Analysis, 2018 & 2026
  • 8.2 Alopecia Market: Leading Players, 2018:
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3 SWOT Analysis
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Latin America
    • 8.3.5. Middle East & Africa
  • 8.4 North America
    • 8.4.1 North America Alopecia market, 2014 - 2026 (USD Million)
    • 8.4.2 U.S.
      • 8.4.2.1 U.S. Alopecia market, 2014 - 2026 (USD Million)
    • 8.4.3 Canada
      • 8.4.3.1 Canada Alopecia market, 2014 - 2026 (USD Million)
  • 8.5. Europe
    • 8.5.1 Europe Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.2 U.K.
      • 8.5.2.1 U.K. Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.3 Germany
      • 8.5.3.1 Germany Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.4 Spain
      • 8.5.4.1 Spain Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.5 France
      • 8.5.5.1 France Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.6 Italy
      • 8.5.6.1 Italy Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.7 Sweden
      • 8.5.7.1 Sweden Alopecia market, 2014 - 2026 (USD Million)
    • 8.5.8 Netherlands
      • 8.5.8.1 Netherlands Alopecia market, 2014 - 2026 (USD Million)
  • 8.6 Asia Pacific
    • 8.6.1 Asia Pacific Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.2 Japan
      • 8.6.2.1 Japan Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.3 India
      • 8.6.3.1 India Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.4 South Korea
      • 8.6.4.1 South Korea Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.5 China
      • 8.6.5.1 China Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.6 Australia
      • 8.6.6.1 Australia Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.7 Taiwan
      • 8.6.7.1 Taiwan Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.8 Vietnam
      • 8.6.8.1 Vietnam Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.9 Thailand
      • 8.6.9.1 Thailand Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.10 Malaysia
      • 8.6.10.1 Malaysia Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.11 Singapore
      • 8.6.11.1 Singapore Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.12 Indonesia
      • 8.6.12.1 Indonesia Alopecia market, 2014 - 2026 (USD Million)
    • 8.6.13 Philippines
      • 8.6.13.1 Philippines Alopecia market, 2014 - 2026 (USD Million)
  • 8.7 Latin America
    • 8.7.1 Latin America Alopecia market, 2014 - 2026 (USD Million)
    • 8.7.2 Brazil
      • 8.7.2.1 Brazil Alopecia market, 2014 - 2026 (USD Million)
    • 8.7.3 Mexico
      • 8.7.3.1 Mexico Alopecia market, 2014 - 2026 (USD Million)
    • 8.7.4 Argentina
      • 8.7.4.1 Argentina Alopecia market, 2014 - 2026 (USD Million)
  • 8.8 MEA
    • 8.8.1 MEA Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.2 South Africa
      • 8.8.2.1 South Africa Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.3 Turkey
      • 8.8.3.1 Turkey Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.4 Egypt
      • 8.8.4.1 Egypt Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.5 Iran
      • 8.8.5.1 Iran Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.6 Israel
      • 8.8.6.1 Israel Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.7 Saudi Arabia
      • 8.8.7.1 Saudi Arabia Alopecia market, 2014 - 2026 (USD Million)
    • 8.8.8 UAE
      • 8.8.8.1 UAE Alopecia market, 2014 - 2026 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Heat Map Analysis
  • 9.3. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 9.4. Vendor Landscape
    • 9.4.1. List of key distributors and channel partners
    • 9.4.2. Key company market share analysis, 2018
  • 9.5. Public Companies
    • 9.5.1. Company market position analysis
    • 9.5.2. Company Market Share
    • 9.5.3. Competitive Dashboard Analysis
  • 9.6. Private Companies
    • 9.6.1. List of key emerging companies
    • 9.6.2. Regional network map
    • 9.6.3. Company market position analysis
  • 9.7 Company Profiles
    • 9.7.1 Cipla, Inc.
      • 9.7.1.1 Company overview
      • 9.7.1.2 Financial performance
      • 9.7.1.3 Product benchmarking
      • 9.7.1.4 Strategic initiatives
    • 9.7.2 Sun Pharmaceuticals Industries Ltd.
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 Johnson & Johnson Services, Inc.
      • 9.7.3.1 Company overview
      • 9.7.3.2 Financial performance
      • 9.7.3.3 Product benchmarking
      • 9.7.3.4 Strategic initiatives
    • 9.7.4 Merck & Co., Inc
      • 9.7.4.1 Company overview
      • 9.7.4.2 Financial performance
      • 9.7.4.3 Product benchmarking
      • 9.7.4.4 Strategic initiatives
    • 9.7.5 Lexington Intl., LLC
      • 9.7.5.1 Company overview
      • 9.7.5.2 Financial performance
      • 9.7.5.3 Product benchmarking
      • 9.7.5.4 Strategic initiatives
    • 9.7.6 Cirrus Hair Centers
      • 9.7.6.1 Company overview
      • 9.7.6.2 Financial performance
      • 9.7.6.3 Product benchmarking
      • 9.7.6.4 Strategic initiatives
    • 9.7.7 Vita-Cos-Med Klett-Loch GmbH
      • 9.7.7.1 Company overview
      • 9.7.7.2 Financial performance
      • 9.7.7.3 Product benchmarking
      • 9.7.7.4 Strategic initiatives
    • 9.7.8 Transitions Hair
      • 9.7.8.1 Company overview
      • 9.7.8.2 Financial performance
      • 9.7.8.3 Product benchmarking
      • 9.7.8.4 Strategic initiatives
    • 9.7.9 Follica, Inc.
      • 9.7.9.1 Company overview
      • 9.7.9.2 Financial performance
      • 9.7.9.3 Product benchmarking
      • 9.7.9.4 Strategic initiatives
    • 9.7.10 Capillus
      • 9.7.10.1 Company overview
      • 9.7.10.2 Financial performance
      • 9.7.10.3 Product benchmarking
      • 9.7.10.4 Strategic initiatives

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: Asia Pacific
  • TABLE 4 Primary interview details: MEA
  • TABLE 5 List of secondary sources
  • TABLE 6 List of abbreviations
  • TABLE 7 North America alopecia market, by country, 2014 - 2026 (USD Million)
  • TABLE 8 North America alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 9 North America alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 10 North America alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 11 North America alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 12 U.S. alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 13 U.S. alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 14 U.S. alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 15 U.S. alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 16 Canada alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 17 Canada alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 18 Canada alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 19 Canada alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 20 Europe alopecia market, by country, 2014 - 2026 (USD Million)
  • TABLE 21 Europe alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 22 Europe alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 23 Europe alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 24 Europe alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 25 U.K. alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 26 U.K. alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 27 U.K. alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 28 U.K. alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 29 Germany alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 30 Germany alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 31 Germany alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 32 Germany alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 33 Spain alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 34 Spain alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 35 Spain alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 36 Spain alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 37 France alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 38 France alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 39 France alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 40 France alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 41 Italy alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 42 Italy alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 43 Italy alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 44 Italy alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 45 Sweden alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 46 Sweden alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 47 Sweden alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 48 Sweden alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 49 Netherlands alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 50 Netherlands alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 51 Netherlands alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 52 Netherlands alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 53 Asia Pacific alopecia market, by country, 2014 - 2026 (USD Million)
  • TABLE 54 Asia Pacific alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 55 Asia Pacific alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 56 Asia Pacific alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 57 Asia Pacific alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 58 Japan alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 59 Japan alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 60 Japan alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 61 Japan alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 62 China alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 63 China alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 64 China alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 65 China alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 66 India alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 67 India alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 68 India alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 69 India alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 70 South Korea alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 71 South Korea alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 72 South Korea alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 73 South Korea alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 74 Australia alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 75 Australia alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 76 Australia alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 77 Australia alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 78 Taiwan alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 79 Taiwan alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 80 Taiwan alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 81 Taiwan alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 82 Vietnam alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 83 Vietnam alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 84 Vietnam alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 85 Vietnam alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 86 Thailand alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 87 Thailand alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 88 Thailand alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 89 Thailand alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 90 Malaysia alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 91 Malaysia alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 92 Malaysia alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 93 Malaysia alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 94 Singapore alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 95 Singapore alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 96 Singapore alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 97 Singapore alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 98 Indonesia alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 99 Indonesia alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 100 Indonesia alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 101 Indonesia alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 102 Philippines alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 103 Philippines alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 104 Philippines alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 105 Philippines alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 106 Latin America alopecia market, by country, 2014 - 2026 (USD Million)
  • TABLE 107 Latin America alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 108 Latin America alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 109 Latin America alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 110 Latin America alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 111 Brazil alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 112 Brazil alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 113 Brazil alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 114 Brazil alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 115 Mexico alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 116 Mexico alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 117 Mexico alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 118 Mexico alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 119 Argentina alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 120 Argentina alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 121 Argentina alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 122 Argentina alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 123 MEA alopecia market, by country, 2014 - 2026 (USD Million)
  • TABLE 124 MEA alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 125 MEA alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 126 MEA alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 127 MEA alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 128 South Africa alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 129 South Africa alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 130 South Africa alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 131 South Africa alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 132 Turkey alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 133 Turkey alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 134 Turkey alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 135 Turkey alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 136 Egypt alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 137 Egypt alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 138 Egypt alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 139 Egypt alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 140 Iran alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 141 Iran alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 142 Iran alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 143 Iran alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 144 Israel alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 145 Israel alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 146 Israel alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 147 Israel alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 148 Saudi Arabia alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 149 Saudi Arabia alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 150 Saudi Arabia alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 151 Saudi Arabia alopecia market, by gender, 2014 - 2026 (USD Million)
  • TABLE 152 UAE alopecia market, by disease type, 2014 - 2026 (USD Million)
  • TABLE 153 UAE alopecia market, by end use, 2014 - 2026 (USD Million)
  • TABLE 154 UAE alopecia market, by sales channel, 2014 - 2026 (USD Million)
  • TABLE 155 UAE alopecia market, by gender, 2014 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary
  • FIG. 6 Market trends &outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Market restraint relevance analysis (Current & future impact)
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 12 Porter's Five Forces Analysis
  • FIG. 13 Alopecia market disease type outlook key takeaways
  • FIG. 14 Alopecia market: Disease type movement analysis
  • FIG. 15 Alopecia areata market, 2014 - 2026 (USD Million)
  • FIG. 16 Cicatricial alopecia market, 2014 - 2026 (USD Million)
  • FIG. 17 Traction alopecia market, 2014 - 2026 (USD Million)
  • FIG. 18 Alopecia totalis market, 2014 - 2026 (USD Million)
  • FIG. 19 Alopecia universalis market, 2014 - 2026 (USD Million)
  • FIG. 20 Androgenetic alopecia market, 2014 - 2026 (USD Million)
  • FIG. 21 Other alopecia market, 2014 - 2026 (USD Million)
  • FIG. 22 Alopecia market end use outlook key takeaways
  • FIG. 23 Alopecia market: End use movement analysis
  • FIG. 24 Dermatology clinic market, 2014 - 2026 (USD Million)
  • FIG. 25 Homecare setting market, 2014 - 2026 (USD Million)
  • FIG. 26 Alopecia market sales channel outlook key takeaways
  • FIG. 27 Alopecia market: Sales channel movement analysis
  • FIG. 28 Prescription market, 2014 - 2026 (USD Million)
  • FIG. 29 OTC market, 2014 - 2026 (USD Million)
  • FIG. 30 Alopecia market gender outlook key takeaways
  • FIG. 31 Alopecia market: Gender movement analysis
  • FIG. 32 Male alopecia market, 2014 - 2026 (USD Million)
  • FIG. 33 Female alopecia market, 2014 - 2026 (USD Million)
  • FIG. 34 Regional market place: Key takeaways
  • FIG. 35 Regional outlook, 2018 & 2026
  • FIG. 36 North America alopecia market, 2014 - 2026 (USD Million)
  • FIG. 37 U.S. alopecia market, 2014 - 2026 (USD Million)
  • FIG. 38 Canada alopecia market, 2014 - 2026 (USD Million)
  • FIG. 39 Europe alopecia market, 2014 - 2026 (USD Million)
  • FIG. 40 U.K. alopecia market, 2014 - 2026 (USD Million)
  • FIG. 41 Germany alopecia market, 2014 - 2026 (USD Million)
  • FIG. 42 Spain alopecia market, 2014 - 2026 (USD Million)
  • FIG. 43 France alopecia market, 2014 - 2026 (USD Million)
  • FIG. 44 Italy alopecia market, 2014 - 2026 (USD Million)
  • FIG. 45 Sweden alopecia market, 2014 - 2026 (USD Million)
  • FIG. 46 Netherlands alopecia market, 2014 - 2026 (USD Million)
  • FIG. 47 Asia Pacific alopecia market, 2014 - 2026 (USD Million)
  • FIG. 48 Japan alopecia market, 2014 - 2026 (USD Million)
  • FIG. 49 China alopecia market, 2014 - 2026 (USD Million)
  • FIG. 50 India alopecia market, 2014 - 2026 (USD Million)
  • FIG. 51 South Korea alopecia market, 2014 - 2026 (USD Million)
  • FIG. 52 Australia alopecia market, 2014 - 2026 (USD Million)
  • FIG. 53 Taiwan alopecia market, 2014 - 2026 (USD Million)
  • FIG. 54 Vietnam alopecia market, 2014 - 2026 (USD Million)
  • FIG. 55 Thailand alopecia market, 2014 - 2026 (USD Million)
  • FIG. 56 Malaysia alopecia market, 2014 - 2026 (USD Million)
  • FIG. 57 Singapore alopecia market, 2014 - 2026 (USD Million)
  • FIG. 58 Indonesia alopecia market, 2014 - 2026 (USD Million)
  • FIG. 59 Philippines alopecia market, 2014 - 2026 (USD Million)
  • FIG. 60 Latin America alopecia market, 2014 - 2026 (USD Million)
  • FIG. 61 Brazil alopecia market, 2014 - 2026 (USD Million)
  • FIG. 62 Mexico alopecia market, 2014 - 2026 (USD Million)
  • FIG. 63 Argentina alopecia market, 2014 - 2026 (USD Million)
  • FIG. 64 MEA alopecia market, 2014 - 2026 (USD Million)
  • FIG. 65 South Africa alopecia market, 2014 - 2026 (USD Million)
  • FIG. 66 Turkey alopecia market, 2014 - 2026 (USD Million)
  • FIG. 67 Egypt alopecia market, 2014 - 2026 (USD Million)
  • FIG. 68 Iran alopecia market, 2014 - 2026 (USD Million)
  • FIG. 69 Israel alopecia market, 2014 - 2026 (USD Million)
  • FIG. 70 Saudi Arabia alopecia market, 2014 - 2026 (USD Million)
  • FIG. 71 UAE alopecia market, 2014 - 2026 (USD Million)
Back to Top